MEDTRONIC HEART VALVES DIVISION EVOLUT PRO PLUS VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
|
Back to Search Results |
|
Model Number EVPROPLUS-29US |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Intimal Dissection (1333); Cardiac Arrest (1762); Death (1802); Vascular System (Circulation), Impaired (2572); Blood Loss (2597)
|
Event Date 09/24/2020 |
Event Type
Death
|
Manufacturer Narrative
|
Product analysis: no product was returned.Conclusion: without the return of the product, no definitive conclusion can be made regarding the clinical observation.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Medtronic received information that following the implant of this transcatheter bioprosthetic valve, when in recovery, the patient arrested.Heart catheterization was performed revealing the right coronary artery was occluded.The coronary artery was stented back open.Upon completion of the catheterization, an aortic angiogram revealed a dissection in the ascending aorta.The cause of the dissection was passing the wire back and forth when trying to do the heart catheterization.It is unknown if the valve or delivery catheter system (dcs) contributed to the dissection.It is possible that patient anatomy contributed to the dissection as there was re-entry to an old dissection flap.Subsequently, the patient died as a result of the dissection and bleeding.
|
|
Manufacturer Narrative
|
Updated data: b5.Additional information was received that the physician could not ascertain the cause of the coronary occlusion, but indicated it may have been from the valve or a result of the dissection.It was confirmed the valve did not migrate from the initial implant depth of 3mm.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Search Alerts/Recalls
|
|
|